128
Views
11
CrossRef citations to date
0
Altmetric
Original Research

A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000

&
Pages 475-483 | Published online: 10 Aug 2017

Figures & data

Table 1 Simplified iron isomaltoside dosing table used in the reference case analysis showing the total recommended iron dose by bodyweight and hemoglobin concentration and the proportions of patients falling into each category

Figure 1 Histograms of bodyweight and hemoglobin distributions in the base case analysis illustrated using a bodyweight bin size of 1 kg (A) and a hemoglobin bin size of 0.5 g/dL (B).

Figure 1 Histograms of bodyweight and hemoglobin distributions in the base case analysis illustrated using a bodyweight bin size of 1 kg (A) and a hemoglobin bin size of 0.5 g/dL (B).

Figure 2 Mean number of infusions per patient (A) and proportion of patients requiring multiple infusions (B).

Figure 2 Mean number of infusions per patient (A) and proportion of patients requiring multiple infusions (B).

Table 2 Base case budget impact outcomes expressed as the cost per treated patient per year

Figure 3 Cost savings with iron isomaltoside relative to iron sucrose (A) and ferric carboxymaltose (B) over a range of mean bodyweights in an average clinical commissioning group.

Abbreviation: GBP, 2016 pounds sterling.
Figure 3 Cost savings with iron isomaltoside relative to iron sucrose (A) and ferric carboxymaltose (B) over a range of mean bodyweights in an average clinical commissioning group.

Table 3 One-way sensitivity analyses around the base case analysis